Research Use Only. Not for human or veterinary use.
HPLC and Mass Spectrometry: How Peptide Purity Is Verified — Tide Front Supply
HPLC and Mass Spectrometry: How Peptide Purity Is Verified
Innovatix Admin · May 25, 2026 · 3 min read
How reverse-phase HPLC and ESI mass spectrometry are used to confirm peptide identity, purity percentage, and batch-to-batch consistency.
Two analytical techniques sit at the heart of peptide quality control: high-performance liquid chromatography (HPLC) for purity quantification, and mass spectrometry (MS) for identity confirmation. Neither technique alone is sufficient; together they constitute the gold standard for batch release.
What HPLC Measures
HPLC physically separates the components of a sample and quantifies each one. For peptides, reverse-phase HPLC (RP-HPLC) is the method of choice. The stationary phase — typically C18, a silica support with 18-carbon alkyl chains — retains hydrophobic compounds preferentially. A mobile phase gradient of increasing acetonitrile concentration (in water, both containing 0.1% TFA to suppress ionisation and sharpen peaks) elutes compounds in order of increasing hydrophobicity.
Detection is by UV absorbance, almost universally at 214–220 nm. At these wavelengths, the peptide bond absorbs strongly, so every peptide-containing species in the sample produces a peak proportional to its quantity — regardless of whether it contains aromatic residues.
Reading a Chromatogram
A chromatogram plots UV absorbance against time. A pure sample produces a single sharp, symmetrical peak. Impurities appear as additional peaks or as shoulder asymmetry on the main peak.
Integration of the area under each peak gives a percentage figure. A 98.5% HPLC purity means 98.5% of the total UV-absorbing area elutes at the retention time assigned to the target peptide. The remaining 1.5% represents all UV-active impurities combined — truncated sequences, oxidized variants, aggregates, or residual protecting groups.
What HPLC does not tell you: whether the main peak corresponds to the correct sequence. A clean but incorrect peptide produces a clean chromatogram.
What ≥98% Purity Means in Practice
For most research applications, ≥98% HPLC purity is the practical threshold for reliable results. At this level:
Dose-response curves are not meaningfully confounded by impurities.
Binding assays (receptor pharmacology, SPR, ITC) produce interpretable data.
In-vitro cytotoxicity experiments are not biased by trace contaminants.
Working with 90–95% purity material is possible for exploratory screening but can introduce noise in quantitative experiments. For publication-quality data, ≥98% is the expectation reviewers will apply.
Mass Spectrometry for Identity Confirmation
Electrospray ionisation mass spectrometry (ESI-MS) measures the mass-to-charge ratio (m/z) of gas-phase ions derived from the sample. For peptides, ESI produces multiply charged ions — a 2.5 kDa peptide might appear as [M+2H]²⁺ and [M+3H]³⁺ ions — allowing accurate mass determination from a relatively simple instrument.
The measured molecular weight is compared to the theoretical molecular weight calculated from the amino acid sequence. Agreement within 1 Da (for peptides under 3 kDa) or within 0.1% of the theoretical mass (for larger peptides) confirms identity.
Common mass shifts that indicate specific problems:
+16 Da: oxidation of methionine or tryptophan.
+1 Da: deamidation of asparagine or glutamine.
-128 Da (approx): deletion of glutamine or lysine.
-114 Da (approx): deletion of asparagine.
A delta of zero means the sequence is correct. Any significant deviation is a reason to reject the batch.
ESI-MS in Practice
Modern analytical HPLC systems are routinely coupled to a single-quadrupole or time-of-flight mass detector (LC-MS). This allows simultaneous collection of the chromatogram and mass spectrum of each eluting peak — the most information-rich format for peptide QC. The main peak fraction is confirmed both chromatographically and by mass within a single run.
What a Certificate of Analysis Contains
A properly formatted CoA for a research peptide includes:
Peptide name and sequence: the claimed primary structure.
Molecular formula and theoretical molecular weight: the reference values for MS comparison.
Observed molecular weight: from ESI-MS, with the charge states observed.
HPLC purity percentage: from the analytical run, with the column and gradient stated.
Lot/batch number: linking the document to a specific manufacturing run.
Manufactured date and expiry (if stated).
Storage recommendation: typically -20°C, lyophilized.
Both HPLC and MS data should be present. A CoA missing either test is incomplete by current industry norms.